SIRT1 and Hepatic steatosis: Both of them concluded that mild overexpression of SIRT1 (2- to 4-fold higher, depending on the tissue) prevented HFD-induced glucose intolerance, insulin resistance and hepatic steatosis, despite no significant alteration in body weight [4,5].